Category list : Pharmaceutical companies
Sort by: Newest first Oldest first A-Z Z-A
-
Government cap on branded medicine prices may be unsustainable, warns ABPI
An ongoing cap on the price of branded medicines to the NHS “may not be sustainable” in the long term, the Association of the British Pharmaceutical Industry has said.
-
Government voices concerns about using legal powers for affordable access to cystic fibrosis drug
The government has said that using its legal power to “break the monopoly” held by drug company Vertex Pharmaceuticals over its combination cystic fibrosis treatment Orkambi would not represent “a quick solution”.ent Orkambi.
-
Drugs companies asked to maintain a six-week stockpile for six months in the event of 'no-deal' Brexit
Pharmaceutical companies have been asked to maintain a rolling six-week stockpile of medicines for six months in the event of a ‘no-deal’ Brexit, the government has confirmed.
-
Pharmaceutical company charged following investigation into deaths of babies
A pharmaceutical firm has been charged with criminal offences following a police investigation into the deaths and illnesses of babies at hospitals in England.
-
Almost 1,500 pharma firms could miss FMD deadline, warns body in charge
Around 1,500 pharmaceutical companies are at risk of failure to comply with the Falsified Medicines Directive because they have yet to start working with the European Medicines Verification Organisation, the body has warned.
-
Exclusive deal for Boots as sildenafil becomes P medicine
Boots UK strikes two-week deal with Pfizer to exclusively sell sildenafil over the counter after its reclassification from a prescription-only medicine to a pharmacy medicine.
-
Dealing with medicines misuse in execution by lethal injection Subscription
New standards of industry best practice have been established for implementing distribution controls on drugs that could be used for execution
-
CCGs failed to declare hundreds of payments from drug companies, BMJ investigation reveals
Clinical commissioning groups in England failed to publicly declare a third of all payments accepted from pharmaceutical companies, the private sector and charities between 2015 and 2017.
-
Pharma companies may be less likely to invest in the UK post-Brexit, MPs told
UK patient involvement in clinical trials will diminish post-Brexit making manufactures less likely to want to invest here, MPs on the House of Commons Health Select Committee were told.
-
Artificial Intelligence: will it change the way drugs are discovered? Subscription
The pharmaceutical industry is beginning to invest in artificial intelligence (AI), with many large pharmaceutical companies partnering with AI start-ups in 2017 in order to develop better diagnostics or biomarkers, to identify drug targets and to design new drugs. But when will the first AI-designed drugs reach the market and will AI permanently change the pharmaceutical industry and the way drugs are discovered?
